← All Sponsors
SPONSOR

IRIS Research and Development, LLC

Total Trials
1
Recruiting
1
Phases
Phase 1
Conditions studied: Rheumatoid ArthritisPemphigus VulgarisGranulomatosis With PolyangiitisSystemic Lupus Erythematosus
NCT06581562 Phase 1
Recruiting

Open-label Single-Center Study to Evaluate the Safety and Efficacy of Combining Rituximab and AB-101 in B-cell Associated Autoimmune Diseases.

Rheumatoid Arthritis
United States View Trial →